Association between dopamine receptor D2 genetic polymorphism TaqIA1 (C t) and susceptibility to alcohol dependence
===================================================================================================================

* Amrita Choudhary
* Upendra Yadav
* Pradeep Kumar
* Vandana Rai

## Abstract

Several studies are published, which investigated dopamine receptor 2 (DRD2) gene TaqIA polymorphism as ris factor for alcohol dependence (AD) with positive and negative association. To derive a more precise estimation of the relationship, a meta-analysis of case-control studies that examined the association between DRD2 gene Taq1A polymorphism and alcohol dependence were performed. Eligible articles were identified through search of databases including PubMed, Science Direct, Springer link and Google Scholar. The association between the DRD2 TaqIA polymorphism and AD susceptibility was conducted using odds ratios (ORs) and 95 % confidence intervals (95 % CIs) as association measure.

A total of 69 studies with 9,125 cases and 9,123 healthy controls were included in current meta-analysis. Results of present analysis showed significant association between DRD2 TaqIA polymorphism and AD risk using a five genetic modes (allele contrast model -OR=1.22, 95% CI=1.13-1.32, p<0.0001; homozygote model -OR= 1.35, 95%CI= 1.18-1.55; p= <0.0001; dominant model -OR= 1.29; 95%CI= 1.20-1.39; p<0.0001; recessive model-OR= 1.21; 95%CI= 1.08-1.36; p= 0.0006). There was no significant association found between In subgroup analysis, TaqIA polymorphism was not significantly associated with AD risk in Asian population under all genetic models, but in Caucasian population TaqIA polymorphism was significantly associated with AD risk.

Overall, results support the hypothesis that DRD2 Taq1A polymorphism plays a role in alcohol dependence.

Keywords
*   DRD2
*   TaqIA
*   Alcohol dependence
*   AD
*   Polymorphism
*   Meta-analysis

## Introduction

Alcoholism dependence (AD) is a complex behavioural and multifactorial disorder often associated with increased risk of developing other behavioural and psychiatric disorders such as anxiety, depression, anti social personality disorder and bipolar disorder, by affecting various neural mechanisms and part of brain with its effect according to the dose of consumption, genetic factors, etc. AD is a psychiatric disorder, with the life time population risk of approximately 5.4%.Family and twins studies support the role of a genetic component in AD. It is widely accepted that the dopamingeric system play a crucial role in the development of psychoactive substance dependence including opiates, cocaine, nicotine and alcohol (Koob and Moal, 2001 Munafò et al., 2001 Lingford-Hughes and Nutt,2003). The dopaminergic system regulates brain reward mechanism (Dick and Foroud,2003 Tupala and Tiihonen,2006), so genes of reward pathway especially dopamine receptors are considered a strong candidate for alcohol dependence. Alcohol stimulates dopamine receptors, which release dopamine in the ventral striatum leading to increased alcohol consumption through mechanisms involving incentive salience attributions and craving (Kienast and Heinz,2006). Aberrant dopamine signaling is implicated in several psychiatric and neurological brain disorders such as schizophrenia, depression, eating disorders, Parkinson’s disease and addiction (Glatt et al., 2003).

Dopamine D2 receptor (DRD2) gene is the most studies polymorphic site in the reward pathway in connection to AD. DRD2 receptor is present throughout the brain but the highest density was reported in substantia nigra, ventral tegmental area, and nucleus accumbens (Boyson et al., 1986Meador-Woodruff et al.,1989 Weiner and Brann,1989). DRD2 gene is present on chromosome 11q23.1 (Grandy et al. 1989 Eubanks et al.,1992), and after transcription it produces two transcripts that encode two isoforms (D2L isoform and D2S isoform). Several polymorphism are reported in DRD2 gene, but the most studied polymorphism is TaqIA polymorphism (rs1800497 C32806T Glu713Lys) in the 3 flanking region of the gene (Thompson et al.,1997). The *DRD2* gene spans approximately 270 kb with about a 250-kb intron separating the first and second exons (Eubanks et al., 1992). The TaqIA polymorphism lies 10,541 bp downstream (C32806T) of the termination codon of the DRD2 gene and fall within ankyrin repeat and kinase domain containing 1 (ANKK1) gene (Noble 2003 Neville et al.,2004). The two alleles are referred to as A2 (cytosine) and A1 (thymine) and the TaqIA genotypes are named A2/A2 (homozygous wid), A2/A1 (heterozygous) and A1/A1 (homozygous).DRD2 Taq1A polymorphism has been associated with reduced D2 receptor availability in the striatum (Thompson et al. 1997; Noble et al. 1991), lower mean relative glucose metabolic rate in dopaminergic regions (Noble et al. 1997), and low receptor density (Pohjalainen et al. 1998).

Blum et a (1990) initially demonstrated an association of the minor *Taq*l A allele (A1) of the DRD2 gene with AD. Since then, several studies have published from different populations, with many affirming this finding (Parsian et al. 1991; Amadeo et al. 1993; Noble et al. 1994 ; Neiswanger et al. 1995; Hietala et al. 1997; Lawford et al. 1997; Vasconceos et al.,2015; Panduro et al.,2017), while others have not (Geijer et al.,1994; Heinz et al.,1996; Sander et al. 1999; Kasiakogia-Worlley et al., 2011; Ragia et al.,2016). Hence, authors performed an update meta-analysis to validate the association between TaqIA polymorphism and alcohol dependence.

## Methods

Meta-analysis was carried out according to Meta-analysis of observational studies in epidemiology (MOOSE) guidelines (Stroup et al.,2000).

### Article Search

Published articles examining the effect of the DRD2 gene Taq1A polymorphisms on the risk of alcohol dependence were identified through electronic database searches in Pubmed, Science direct, Google scholar and springer link. Databases searches were done from January 1990 (the year that DRD2 Taq1A polymorphisms were first reported as a risk factor for AD. Electronic database searches were supplemented by manual searches of references of review and published research articles. The following terms were used: ‘‘Dopamine receptor 2’’, ‘‘DRD2,’’ ‘‘Taq1A’’, ‘‘Alcoholism’’, ‘‘Alcohol dependence’’, ‘‘polymorphism’’. Literature search included all languages. If any study reported results on different subpopulations according to ethnicity, each subpopulation was included as a separate study in the meta-analysis.

### Inclusion criteria

Studies included in our meta-analyses were based on the following criteria: (1) published should be published, (2) article should reported sample size, ancestry of samples etc ; and (3) sample not duplicative of other reports. Studies were excluded if: (1) incomplete raw data/information and not providing complete information for number of genotype and/or allele number calculation, (3) studies based on pedigree and (4) review, letter to editors and book chapters.

### Data Extraction

From each of the included articles the following information was extracted: first author family name, year of publication, country, ethnicity, study design, number of controls and cases, and evidence of HWE in controls.

### Statistical Analyses

Crude odds ratios (ORs) with 95% confidence intervals (CIs) were calculated under five genetic models: the allele model (mutant [M] allele vs. wild [W] allele), the dominant model (MM+WM vs. WW), the recessive model (MM vs. WM+WW), the homozygous model (MM vs. WW), and the heterozygous model (WM vs. WW). The OR was estimated by using fixed effects (Mantel and Haenszel,1959) and random effects (DerSimonian and Laird,1986) model depending upon heterogeneity. If higher heterogeneity between studies then the pooled OR is estimated using the RE model (Zintzaras and Ioannidis, 2004; Zintzaras et al., 2006). The heterogeneity was tested using the Q-statistic and was quantified using the I2 statistic (Higgins and Thompson,2002). Subgroup analysis based on ethnicity of subjects was performed to evaluate the stability of the results and sensitivity analysis was done by removing the studies not in Hardy–Weinberg equilibrium (HWE), and studies with small sample size. Control population of each study was tested for Hardy–Weinberg Equilibrium (HWE) using the chi square test.

Funnel plot and the Egger regression asymmetry test (Egger et al.,1997) were used for assessment of publication bias. P values were two-tailed with a significance level of 0.05. All analyses were done by the program Meta-Analyst (Wallace et al.,2013) and Mix version 1.7 (Bax et al.,2006).

## Results

### Literature Search

The flow chart of the study selection process is shown in Figure 1. Initial search of Pubmed, Science direct, Google Scholar and Springer Link databases, total 511 articles were retrieved, but 301 articles did not meet the inclusion criteria after reviewing abstract. Out of remaining 210 articles, 142 articles also excluded as not following inclusion criteria. After applying inclusion and exclusion criteria, total 68 studies were found suitable for the present meta-analysis (Blum et al., 1990; Bolos et al. 1990; Blum et al.,1991; Comings et al. 1991; Gelernter et al. 1991; Parsian et al. 1991; Schwab et al., 1991; Amadeo et al. 1993; Cook et al. 1992;Goldman et al. 1992; Arinami et al. 1993; Goldman et al. 1993; Comings et al. 1994; Geijer et al.,1994; Noble et al. 1994 ; Neiswanger et al. 1995; Sander et al. 1995; Chen et al. 1996; Finckh et al.,1996; Heinz et al.,1996; Lu et al. 1996; Chen et al. 1997; Goldman et al., 1997; Hietala et al. 1997; Kono et al. 1997; Lawford et al. 1997; Lee et al. 1997; Ishiguro et al. 1998; Gelernter and Kranzler 1999; Ovchinnikov et al. 1999; Sander et al. 1999; Amadeo et al. 2000; Bau et al. 2000; Gorwood et al. 2000; Samochowiec et al. 2000; Anghelescu et al. 2001; Lu et al., 2001; Matsushita et al. 2001; Pastorelli et al. 2001;Shaikh et al. 2001; Limosin et al. 2002; Foley et al. 2004; Konishi et al. 2004; Berggren et al. 2006;Freire et al. 2006; Huang et al. 2007; Sakai et al. 2007; Wang et al. 2007; Joe et al.2008; Namkoong et al. 2008; Ponce et al., 2008; Samochowiec et al., 2008; Wu et al., 2008; Kraschewski et al., 2009; Berggren et al.,2010; Bhaskar et al., 2010; Kovanen et al., 2010; Prasad et al.,2010; Kasiakogia-Worlley et al., 2011; Landgren et al., 2011; Mignini et al., 2012; Schellekens et al. 2012; Singh et al., 2013; Jasiewicz et al., 2014; Vasconceos et al.,2015; Ragia et al.,2016; Panduro et al.,2017). Panduro et al. (2017) analyzed samples from two population, so in present meta-analysis data of both the population were included as separate studies, hence total number of studies included in current meta-analysis was sixty nine.

![Figure 1.](http://medrxiv.org/http://medrxiv.stage.highwire.org/content/medrxiv/early/2020/04/18/2020.04.15.20066498/F1.medium.gif)

[Figure 1.](http://medrxiv.org/content/early/2020/04/18/2020.04.15.20066498/F1)

Figure 1. Study selection flow diagram

### Characteristic of Eligible Studies

First study was published in 1990 (Blum et al., 1990) and recent study was published in 2017 (Panduro et al.,2017). In one study, authors mentioned only allele numbers. A total of 2591 subjects were involved in this meta-analysis, including 9125 AD cases and 9123 healthy controls. In cases, CC, CT and TT genotypes were 3903, 3063 and 1020 respectively. Out of 69 studies, control population of four studies (Bolos et al. 1990; Schwab et al., 1991; Kovanen et al.,2010; Panduro et al.,2017)are not in Hardy Weinberg equilibrium. Twenty of 69 studies were conducted in Asian populations, and the other 49 studies in Caucasian populations.

### Meta-analysis

Table 2 summarizes the ORs with corresponding 95% CIs for association between DRD2 Taq IA polymorphism and risk of alcohol dependence in allele contrast ((T vs. C/A1 vs. A2)), homozygote (TT vs. CC/A1A1 vs. A2A2), dominant (TT+CT vs. CC/A1A1+A1A2 vs. A2A2), recessive (TT vs. CT+CC/ A1A1 vs. A1A2 + A2A2) and co-dominant (CT vs. CC/A1A2 vs. A2A2) models.

View this table:
[Table 1.](http://medrxiv.org/content/early/2020/04/18/2020.04.15.20066498/T1)

Table 1. Details of included sixty nine studies

View this table:
[Table 2.](http://medrxiv.org/content/early/2020/04/18/2020.04.15.20066498/T2)

Table 2. 
Summary estimates for the odds ratio (OR) in various allele/genotype contrasts, the significance level (p value) of heterogeneity test (Q test), and the I2 metric: overall analysis

Allele contrast meta-analysis revealed a modest significant association between AD and DRD2 gene T allele (T vs. C) with both fixed effects (OR= 1.18, 95% CI= 1.12-1.24, p<0.0001) and random effects model(OR=1.22, 95% CI=1.13-1.32, p<0.0001) (Table 2). Heterogeneity was less than 50% (I2=41.02), hence fixed effect mode was adopted. Results showed an increased risk of AD among mutant homozygote variants (TT vs.CC; homozygote model), with both fixed (OR= 1.35, 95%CI= 1.18-1.55; p= <0.0001) and random (OR= 1.39; 95%CI= 1.19-1.61; p<0.0001) effect models.

Mutant genotypes (TT+CT vs.CC; dominant model) showed positive significant association with AD using both fixed (OR= 1.29; 95%CI= 1.20-1.39; p<0.0001) and random (OR= 1.29; 95%CI= 1.18-1.453; p<0.0001) effect models (Table 2). Similarly the recessive genotypes model (TT vs. CT+CC) also showed significant association with AD with both fixed (OR= 1.21; 95%CI= 1.08-1.36; p= 0.0006) and random (OR= 1.26; 95%CI= 1.11-1.43; p= 0.0004) effect models (Table 2).

### Sub-group Analysis

Authors also performed ethnicity based sub-group analysis. Out of 69 studies, 20 studies were from Asia and 49 studies were from Caucasian population. In Asian population (number of studies= 20; 1410/1700 cases/controls), meta-analysis using all five genetic modes did not show any significant association (allele contrast: OR= 1.23, 95% CI= 1.11-1.37, p=0.87; dominant model: OR = 1.31, 95% CI= 1.13-153, p=0.71) (Figure 3). Results of Caucasian studies (number of studies= 49; 7715/7423 cases/controls) meta-analysis using a five genetic modes indicated significant association with both fixed and random effects model, but fixed effect mode was adopted due to less heterogeneity (allele contrast: OR= 1.23, 95% CI= 1.23-1.35, p=0.00; dominant model: OR = 1.31, 95% CI= 1.16-147, p=0.00) (Figure 4).

![Figure 2.](http://medrxiv.org/http://medrxiv.stage.highwire.org/content/medrxiv/early/2020/04/18/2020.04.15.20066498/F2.medium.gif)

[Figure 2.](http://medrxiv.org/content/early/2020/04/18/2020.04.15.20066498/F2)

Figure 2. Forest Plot of dominant model of 69 studies

![Figure 3.](http://medrxiv.org/http://medrxiv.stage.highwire.org/content/medrxiv/early/2020/04/18/2020.04.15.20066498/F3.medium.gif)

[Figure 3.](http://medrxiv.org/content/early/2020/04/18/2020.04.15.20066498/F3)

Figure 3. Forest plot of dominant model of Asian studies

![Figure 4.](http://medrxiv.org/http://medrxiv.stage.highwire.org/content/medrxiv/early/2020/04/18/2020.04.15.20066498/F4.medium.gif)

[Figure 4.](http://medrxiv.org/content/early/2020/04/18/2020.04.15.20066498/F4)

Figure 4. Forest plot of homozygote model of Caucasian studies

![Figure 5.](http://medrxiv.org/http://medrxiv.stage.highwire.org/content/medrxiv/early/2020/04/18/2020.04.15.20066498/F5.medium.gif)

[Figure 5.](http://medrxiv.org/content/early/2020/04/18/2020.04.15.20066498/F5)

Figure 5. Funnel plot of allele contrast model of 69 studies

### Sensitivity analysis

In allele contrast meta-analysis, sensitivity analysis performed by exclusion of five studies in which control population was not in HWE. Result of meta-analysis by exclusion of these five studies not in HWE (Bolos et al.,1990; Schwab et al.,1991; Kovanen et al.,2010; Panduro et al., 2017-Guadalaraja; Panduro et al., 2017-Tepic) showed that odds ratio was not increased. In addition, the influence of each study on the pooled OR was examined by repeating the meta-analysis while omitting each study one at a time. The results suggested that no individual study significantly affected the pooled ORs.

### Publication bias

Begg’s funnel plot and Egger’s test were performed to assess the publication bias. The shape of funnel plots did not reveal any evidence of obvious asymmetry in all genetic models except allele contrast (Figure). Egger’s test was used to provide statistical evidence and p values of Egger’s tests were more than 0.05 (p=0.003 for T *vs* C; p=0.42 for TT *vs* CC; p=0.19 for CT *vs* CC; p=0.18 for TT+CT *vs* CC; and p=0.06 for TT *vs* CT+CC). The results did not show any evidence of publication bias except in allele contrast meta-analysis of total studies. The detailed data were given in table 2.

## Discussion

It is well recognized that there is individual susceptibility to AD even within the same environmental exposure. Main factor, including polymorphisms of genes involved in reward cascade pathway may have accounted for this difference. A1 allele of the DRD2 Taq1A polymorphism was reported to be associated with altered/reduced D2 receptor expression in the brain and may confer susceptibility to AD (Pohjalainen et al., 1998).

Four meta-analyses are published and demonstrated a moderate effect of the Taq1A polymorphism on AD (Munafo et al. 2007; Le Foll et al. 2009; Smith et al., 2008; Wang et al., 2013). Present meta-analysis included the largest number of studies so far investigating the association between the Taq1A polymorphism and AD. Sixty-nine eligible studies published up to 2017 were considered, including 9,125 cases and 9,123 healthy controls. Our results provide strong evidence of the association between the Taq1A polymorphism and AD, especially in the European population. Heterogeneity and publication bias are not present and sensitivity analysis showed that the results from both allelic and genotypic meta-analyses are stable and not influenced by any individual study.

Meta-analysis offers a powerful method to synthesize information of independent studies with similar target (Ioannidis et al., 2002). Several meta-analysis are published, which evaluated effects of polymorphism in susceptibility of diseases/disorders-down syndrome (Rai,2011; Rai et al., 2017; Rai and Kumar, 2018), cleft lip and palate (Rai,2014, 2017), Glucose-6-phosphate dehydrogenase deficiency (Kumar et al.,2016), male infertility (Rai and Kumar,2017),schizophrenia (Yadav et al., 2015; Rai et al., 2017), obsessive compulsive disorder (Kumar and Rai,2019), depression (Rai,2014,2017), epilepsy (Rai and Kumar,2018),Alzheimers disease (Rai, 2016), esophageal cancer (Kumar and Rai, 2018), prostate cancer (Yadav et al.,2016), breast cancer (Kumar et al., 2015; Rai et al.,2017), digestive tract cancer (Yadav et al.,2018), ovary cancer (Rai, 2016), endometrial cancer (Kumar et al., 2018), uterine leiomyioma (Kumar and Rai, 2018), MTHFR gene frequency (Yadav et al.,2018), and MTRR gene frequency (Yadav et al.,2019).

Along with strengths, there were also few limitations in current meta-analysis like-(i) crude OR was used in meta-analysis, (ii) other risk factors among the subjects in the available studies, such as smoking status, diet etc were not considered and (iii) only single gene polymorphism was considered and gene -gene or gene-environment interactions were not considered.

In conclusion, pooled analysis of data from 69 separate populations indicates that the DRD2 Taq1A polymorphism is associated with significant risk of AD. Results of subgroup analyses showrd that TaqIA polymorphism is not risk factor for AD in Asian population, but this polymorphism is provides susceptibility for AD in Caucasian population. Future large-scale, population-based association studies are now need of the hour to investigate potential gene–gene and gene–environment interactions involving the DRD2 Taq1A polymorphism in determining risk of AD.

## Data Availability

All data available in the manuscript.

## Conflict of Interest

None

*   Received April 15, 2020.
*   Revision received April 15, 2020.
*   Accepted April 18, 2020.


*   © 2020, Posted by Cold Spring Harbor Laboratory

This pre-print is available under a Creative Commons License (Attribution-NoDerivs 4.0 International), CC BY-ND 4.0, as described at [http://creativecommons.org/licenses/by-nd/4.0/](http://creativecommons.org/licenses/by-nd/4.0/)

## References

1.  Amadeo S, Abbar M, Fourcade ML, Waksman G, Leroux MG, Madec A et al. D2 dopamine receptor gene and alcoholism.J Psychiatr Res 1993; 27: 173–179.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/0022-3956(93)90005-M&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=8103560&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1993LP64900005&link_type=ISI) 

2.  Amadeo S, Noble EP, Fourcade-Amadeo ML, Tetaria C, Brugiroux MF, Nicolas L, Deparis X, Elbaz A, Zhang X, Ritchie T, Martin PV, Mallet J (2000) Association of D2 dopamine receptor and alcohol dehydrogenase 2 genes with Polynesian alcoholics. Eur Psychiatry 15:97–102.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S0924-9338(00)00206-6&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=10881205&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 

3.  Anghelescu I, Germeyer S, Muller MJ, Klawe C, Singer P, Dahmen N, Wetzel H, Himmerich H, Szegedi A (2001) No association between the dopamine d2 receptor taqi a1 allele and earlier age of onset of alcohol dependence according to different specified criteria. Alcohol Clin Exp Res 25:805–809.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1111/j.1530-0277.2001.tb02283.x&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=11410714&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000169312700003&link_type=ISI) 

4.  Arinami T, Itokawa M, Komiyama T, Mitsushio H, Mori H, Mifune H, Hamaguchi H, Toru M (1993) Association between severity of alcoholism and the A1 allele of the dopamine D2 receptor gene TaqI A RFLP in Japanese. Biol Psychiatry 33:108–114.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/0006-3223(93)90309-2&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=8094979&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1993KL77900006&link_type=ISI) 

5.  Bau CH, Almeida S, Hutz MH (2000) The TaqI A1 allele of the dopamine D2 receptor gene and alcoholism in Brazil: association and interaction with stress and harm avoidance on severity prediction. Am J Med Genet 96:302–306.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/1096-8628(20000612)96:3<302::AID-AJMG13>3.0.CO;2-I&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=10898904&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000087386700013&link_type=ISI) 

6.  Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KG. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol. 2006; 6:50–58.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/1471-2288-6-50&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=17038197&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 

7.  Berggren U, Fahlke C, Aronsson E, Karanti A, Eriksson M, Blennow K, Thelle D, Zetterberg H, Balldin J (2006) The taqI DRD2 A1 allele is associated with alcohol-dependence although its effect size is small. Alcohol Alcohol 41:479–485.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/alcalc/agl043&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=16751215&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000240587600002&link_type=ISI) 

8.  Bhaskar LV, Thangaraj K, Non AL, Singh L, Rao VR (2010) Population-based case–control study of DRD2 gene polymorphisms and alcoholism. J Addict Dis 29:475–480.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1080/10550887.2010.509274&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=20924884&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 

9.  Blum K, Noble EP, Sheridan PJ, Finley O, Montgomery A, Ritchie T, Ozkaragoz T, Fitch RJ, Sadlack F, Sheffield D et al. (1991) Association of the A1 allele of the D2 dopamine receptor gene with severe alcoholism. Alcohol 8:409–416.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/0741-8329(91)90693-Q&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=1839129&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1991GL86100014&link_type=ISI) 

10. Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Jagadeeswaran P, Nogami H, Briggs AH, Cohn JB (1990) Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA 263:2055–2060.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1001/jama.1990.03440150063027&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=1969501&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1990CY68900020&link_type=ISI) 

11. Bolos AM, Dean M, Lucas-Derse S, Ramsburg M, Brown GL, Goldman D (1990) Population and pedigree studies reveal a lack of association between the dopamine D2 receptor gene and alcoholism. JAMA 264:3156–3160.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1001/jama.1990.03450240058040&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=1979357&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1990EN61400035&link_type=ISI) 

12. Boyson SJ, McGonigle P, Molinoff PB (1986) Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain. J Neurosci 6(11):3177–3188.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6Njoiam5ldXJvIjtzOjU6InJlc2lkIjtzOjk6IjYvMTEvMzE3NyI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIwLzA0LzE4LzIwMjAuMDQuMTUuMjAwNjY0OTguYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 

13. Chen CH, Chien SH, Hwu HG (1996) Lack of association between TaqI A1 allele of dopamine D2 receptor gene and alcohol-use disorders in atayal natives of Taiwan. Am J Med Genet 67:488–490.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/(SICI)1096-8628(19960920)67:5<488::AID-AJMG10>3.0.CO;2-J&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=8886168&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1996VJ22300010&link_type=ISI) 

14. Chen WJ, Lu ML, Hsu YP, Chen CC, Yu JM, Cheng AT (1997) Dopamine D2 receptor gene and alcoholism among four aboriginal groups and Han in Taiwan. Am J Med Genet 74: 129–136.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/(SICI)1096-8628(19970418)74:2<129::AID-AJMG3>3.0.CO;2-P&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=9129710&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1997WV79700003&link_type=ISI) 

15. Comings DE, Comings BG, Muhleman D, Dietz G, Shahbahrami B, Tast D et al. The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. J Am Med Assoc 1991; 266: 1793–1800.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1001/jama.1991.03470130073032&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=1832466&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1991GG55100031&link_type=ISI) 

16. Comings DE, Muhleman D, Ahn C, Gysin R, Flanagan SD. The dopamine D2 receptor gene: a genetic risk factor in substance abuse. Drug Alcohol Depend 1994; 34: 175–180.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/0376-8716(94)90154-6&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=8033754&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1994ND73300001&link_type=ISI) 

17. Cook BL, Wang ZW, Crowe RR, Hauser R, Freimer M (1992) Alcoholism and the D2 receptor gene. Alcohol Clin Exp Res 16:806–809.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1111/j.1530-0277.1992.tb00683.x&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=1356317&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1992JK61200027&link_type=ISI) 

18. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/0197-2456(86)90046-2&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=3802833&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1986F013900001&link_type=ISI) 

19. DM, Foroud Dick T: Candidate genes for alcohol dependence: a review of genetic evidence from human studies. Alcohol Clin Exp Res 2003,27:868–79.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/01.ALC.0000065436.24221.63&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=12766633&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000183083500017&link_type=ISI) 

20. Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYm1qIjtzOjU6InJlc2lkIjtzOjEyOiIzMTUvNzEwOS82MjkiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyMC8wNC8xOC8yMDIwLjA0LjE1LjIwMDY2NDk4LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 

21. Eubanks JH, Djabali M, Selleri L, Grandy DK, Civelli O, McElligott DL, Evans GA (1992) Structure and linkage of the D2 dopamine receptor and neural cell adhesion molecule genes on human chromosome 11q23. Genomics 14(4):1010–1018.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S0888-7543(05)80124-7&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=1478642&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1992KE78500024&link_type=ISI) 

22. Finckh U, von Widdern O, Giraldo-Velasquez M, Podschus J, Dufeu P, Sander T, Harms H, Schmidt LG, Rommelspacher H, Rolfs A (1996) No association of the structural dopamine D2 receptor (DRD2) variant 311Cys with alcoholism. Alcohol Clin Exp Res 20:528–532.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1111/j.1530-0277.1996.tb01087.x&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=8727249&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1996UM27000021&link_type=ISI) 

23. Foley PF, Loh EW, Innes DJ, Williams SM, Tannenberg AE, Harper CG, Dodd PR (2004) Association studies of neurotransmitter gene polymorphisms in alcoholic Caucasians. Ann N Y Acad Sci 1025:39–46.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1196/annals.1316.005&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=15542698&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000226975200005&link_type=ISI) 

24. Freire MT, Marques FZ, Hutz MH, Bau CH (2006) Polymorphisms in the DBH and DRD2 gene regions and smoking behavior. Eur Arch Psychiatry Clin Neurosci 256:93–97.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s00406-005-0610-x&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=16032443&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000236114400006&link_type=ISI) 

25. Geijer T, Neiman J, Rydberg U, Gyllander A, Jonsson E, Sedvall G, Valverius P, Terenius L (1994) Dopamine D2-receptor gene polymorphisms in Scandinavian chronic alcoholics. Eur Arch Psychiatry Clin Neurosci 244:26–32.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/BF02279808&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=7918698&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1994NR60900004&link_type=ISI) 

26. Gelernter J, Kranzler H (1999) D2 dopamine receptor gene (DRD2) allele and haplotype frequencies in alcohol dependent and control subjects: no association with phenotype or severity of phenotype. Neuropsychopharmacology 20:640–649.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S0893-133X(98)00110-9&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=10327432&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000080037800012&link_type=ISI) 

27. Gelernter J, O’Malley S, Risch N, Kranzler HR, Krystal J, Merikangas K, Kennedy JL, Kidd KK (1991) No association between an allele at the D2 dopamine receptor gene (DRD2) and alcoholism. JAMA 266:1801–1807.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1001/jama.1991.03470130081033&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=1832467&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1991GG55100032&link_type=ISI) 

28. Gingrich JA, Caron MG (1993) Recent advances in the molecular biology of dopamine receptors. Annu Rev Neurosci 16:299–321.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1146/annurev.ne.16.030193.001503&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=8460895&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1993KR72400014&link_type=ISI) 

29. Glatt SJ, Faraone SV, Tsuang MT. (2003)Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia. Mol Psychiatry. 8(11):911–5.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1038/sj.mp.4001321&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=14593428&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000186453900005&link_type=ISI) 

30. Goldman D, Brown GL, Albaugh B, Robin R, Goodson S, Trunzo M, Akhtar L, Lucas-Derse S, Long J, Linnoila M et al. (1993) DRD2 dopamine receptor genotype, linkage disequilibrium, and alcoholism in American Indians and other populations. Alcohol Clin Exp Res 17:199–204.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1111/j.1530-0277.1993.tb00749.x&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=8488955&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 

31. Goldman D, Dean M, Brown GL, Bolos AM, Tokola R, Virkkunen M, Linnoila M (1992) D2 dopamine receptor genotype and cerebrospinal fluid homovanillic acid, 5-hydroxyindoleacetic acid and3-methoxy-4-hydroxyphenylglycol in alcoholics in Finland and the United States. Acta Psychiatr Scand 86:351–357.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=1283042&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1992KB40800006&link_type=ISI) 

32. Goldman D, Urbanek M, Guenther D, Robin R, Long JC. Linkage and association of a functional DRD2 variant [Ser311Cys] and DRD2 markers to alcoholism, substance abuse and schizophrenia in Southwestern American Indians. Am J Med Genet 1997; 74: 386–394.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/(SICI)1096-8628(19970725)74:4<386::AID-AJMG9>3.0.CO;2-N&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=9259374&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1997XP26800009&link_type=ISI) 

33. Gorwood P, Batel P, Gouya L, Courtois F, Feingold J, Ades J (2000a) Reappraisal of the association between the DRD2 gene, alcoholism and addiction. Eur Psychiatry 15:90–96.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S0924-9338(00)00207-8&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=10881204&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000086351600002&link_type=ISI) 

34. Grandy DK, Litt M, Allen L, Bunzow JR, Marchionni M, Makam H, Reed L, Magenis RE, Civelli O. (1989) The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am J Hum Genet. 45(5):778–85
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=2573278&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1989AZ04900014&link_type=ISI) 

35. Heinz A, Sander T, Harms H, Finckh U, Kuhn S, Dufeu P, Dettling M, Graf K, Rolfs A, Rommelspacher H, Schmidt LG (1996) Lack of allelic association of dopamine D1 and D2 (TaqIA) receptor gene polymorphisms with reduced dopaminergic sensitivity to alcoholism. Alcohol Clin Exp Res 20:1109–1113.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1111/j.1530-0277.1996.tb01954.x&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=8892535&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1996VH52000023&link_type=ISI) 

36. Hietala J, Pohjalainen T, Heikkila-Kallio U, West C, Salaspuro M, Syvalahti E. Allelic association between D2 but not D1 dopamine receptor gene and alcoholism in Finland. Psychiatr Genet 1997; 7: 19–25.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=9264134&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1997XM98200003&link_type=ISI) 

37. Higgins JP, Thompson SE. uantifying heterogeneity in a meta-analysis. Stat Med. 002;21:1539–58.
    
    

38. Himei A, Koh J, Sakai J, Inada Y, Akabame K, Yoneda H. (2002)The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141C Ins/Del polymorphisms. Psychiatry Clin Neurosci. 2002 Feb;56(1):97–102.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=11929577&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 

39. Huang W, Payne TJ, Ma JZ, Beuten J, Dupont RT, Inohara N, Li MD (2009) Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American sample. Neuropsychopharmacology 34:319–330.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=18354387&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 

40. Ioannidis JP, Rosenberg PS, Goedert JJ, O’Brien TR. International meta-analysis of HIV host genetics. Commentary: meta-analysis of individual participants’ data in genetic epidemiology, Am. J. Epidemiol. 156 (2002)204–210.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/aje/kwf031&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=12142254&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000177055400002&link_type=ISI) 

41. Ishiguro H, Arinami T, Saito T, Akazawa S, Enomoto M, Mitushio H et al. Association study between the -141C Ins/Del and TaqI A polymorphisms of the dopamine D2 receptor gene and alcoholism. Alcohol Clin Exp Res 1998; 22: 845–848.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1111/j.1530-0277.1998.tb03877.x&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=9660310&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000074294100013&link_type=ISI) 

42. Jasiewicz A, Samochowiec A, Samochowiec J, Malecka I, Suchanecka A, Grzywacz A (2014) Suicidal Behavior and Haplotypes of the Dopamine Receptor Gene (DRD2) and ANKK1 Gene Polymorphisms in Patients with Alcohol Dependence – Preliminary Report. PLoS One. 2014; 9(11): e111798.
    
    

43. Joe KH, Kim DJ, Park BL, Yoon S, Lee HK, Kim TS, Cheon YH, Gwon DH, Cho SN, Lee HW, Namgung S, Shin HD (2008) Genetic association of DRD2 polymorphisms with anxiety scores among alcohol-dependent patients. Biochem Biophys Res Commun 371:591–595.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=18307984&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 

44. Kasiakogia-Worlley K, McQuillin A, Lydall GJ, Patel S, Kottalgi G, Gunwardena P, Cherian R, Rao H, Hillman A, Gobikrishnan N, Douglas E, Qureshi SY, Jauhar S, Ball D, Okane A, Owens L, Dedman A, Sharp SI, Kandaswamy R, Guerrini I, Thomson AD, Smith I, Dar K, Morgan MY, Kienast T, Heinz A (2006) Dopamine and the diseased brain. CNS Neurol Disord: Drug Targets 5:109–131.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.2174/187152706784111560&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=16613557&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 

45. Konishi T, Calvillo M, Leng AS, Lin KM, Wan YJ (2004a) Polymorphisms of the dopamine D2 receptor, serotonin transporter, and GABA(A) receptor beta(3) subunit genes and alcoholism in Mexican-Americans. Alcohol 32:45–52.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.alcohol.2003.11.002&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=15066703&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 

46. Kono Y, Yoneda H, Sakai T, Nonomura Y, Inayama Y, Koh J, Sakai J, Inada Y, Imamichi H, Asaba H (1997) Association between early onset alcoholism and the dopamine D2 receptor gene. Am J Med Genet 74:179–182.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/(SICI)1096-8628(19970418)74:2<179::AID-AJMG13>3.0.CO;2-F&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=9129720&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1997WV79700013&link_type=ISI) 

47. Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001; 24: 97–129.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S0893-133X(00)00195-0&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=11120394&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000166018000001&link_type=ISI) 

48. Kovanen L, Saarikoski ST, Haukka J, Pirkola S, Aromaa A, Lonnqvist J, Partonen T (2010) Circadian clock gene polymorphisms in alcohol use disorders and alcohol consumption. Alcohol Alcohol 45:303–311.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/alcalc/agq035&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=20554694&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 

49. Kraschewski A, Reese J, Anghelescu I, Winterer G, Schmidt LG, Gallinat J, Finckh U, Rommelspacher H, Wernicke C (2009) Association of the dopamine D2 receptor gene with alcohol dependence: haplotypes and subgroups of alcoholics as key factors for understanding receptor function. Pharmacogenet Genomics 19:513–527.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/FPC.0b013e32832d7fd3&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=19603545&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000267619000004&link_type=ISI) 

50. Kumar P, Yadav U, Rai V. 2015. Methylenetetrahydrofolate reductase gene C677T polymorphism and breast cancer risk: Evidence for genetic susceptibility. Meta Gene, 6 : 72–84.
    
    

51. Kumar P, Yadav U, Rai V (2016) Prevalence of glucose 6-pohsphate dehydrogenase deficiency in India: An updated meta-analysis. Egypt J Med Hum Genet. 2016; 17: 295–302.
    
    

52. Kumar P, Rai V. MTHFR C677T polymorphism and risk of esophageal cancer: An updated meta-analysis. The Egyptian Journal of Medical Human Genetics. 2018; 19: 273–284.
    
    

53. Kumar P, Singh G, Rai V. Evaluation of COMT Gene rs4680 Polymorphism as a Risk Factor for Endometrial Cancer. Ind J Clin Biochem. 2018; doi.org/10.1007/s12291-018-0799-x.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s12291-018-0799-x&link_type=DOI) 

54. Kumar P, Rai V.2018.Catechol-O-Methyltransferase Val158Met polymorphism and susceptibility to Uterine Leiomyoma. Jacobs Journal of Gynecology and Obstetrics,5(1): 043.
    
    

55. Kumar P, Rai V. Catechol-O-methyltransferase gene Val158Met polymorphism and obsessive compulsive disorder susceptibility: a meta-analysis. Metab. Brain Dis. 2020; 35:242-251.ISSN 0885-7490.
    
    

56. Landgren S, Berglund K, Jerlhag E, Fahlke C, Balldin J, Berggren U, Zetterberg H, Blennow K, Engel JA. (2011)Reward-related genes and personality traits in alcohol-dependent individuals: a pilot case control study. Neuropsychobiology. 64(1):38–46.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=21606657&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 

57. Lawford BR, Young RM, Rowell JA, Gibson JN, Feeney GF, Ritchie TL, Syndulko K, Noble EP (1997) Association of the D2 dopamine receptor A1 allele with alcoholism: medical severity of alcoholism and type of controls. Biol Psychiatry 41:386–393.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S0006-3223(96)00478-7&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=9034533&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1997WG39700002&link_type=ISI) 

58. Le Foll B, Gallo A, Le Strat Y, Lu L, Gorwood P (2009) Genetics of dopamine receptors and drug addiction: a comprehensive review. Behav Pharmacol 20:1–17.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/FBP.0b013e3283242f05&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=19179847&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000263895000001&link_type=ISI) 

59. Lee MS, Lee KJ, Kwak DI (1997) No association between the dopamine D2 receptor gene and Korean alcoholism. Psychiatr Genet 7:93–95.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=9285968&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1997XU02600007&link_type=ISI) 

60. Limosin F, Gorwood P, Loze JY, Dubertret C, Gouya L, Deybach JC, Ades J (2002) Male limited association of the dopamine receptor D2 gene TaqI a polymorphism and alcohol dependence. Am J Med Genet 112:343–346.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/ajmg.10712&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=12376935&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000178568700006&link_type=ISI) 

61. Lingford-Hughes A, Nutt D. Neurobiology of addiction and implications for treatment. Br J Psychiatry 2003; 182: 97–100.
    
    [FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiRlVMTCI7czoxMToiam91cm5hbENvZGUiO3M6MTA6ImJqcHJjcHN5Y2giO3M6NToicmVzaWQiO3M6ODoiMTgyLzIvOTciO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyMC8wNC8xOC8yMDIwLjA0LjE1LjIwMDY2NDk4LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 

62. Lu RB, Ko HC, Chang FM, Castiglione CM, Schoolfield G, Pakstis AJ, Kidd JR, Kidd KK (1996) No association between alcoholism and multiple polymorphisms at the dopamine D2 receptor gene (DRD2) in three distinct Taiwanese populations. Biol Psychiatry 39:419–429.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/0006-3223(95)00182-4&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=8679787&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1996UC69300004&link_type=ISI) 

63. Lu RB, Lee JF, Ko HC, Lin WW (2001) Dopamine D2 receptor gene (DRD2) is associated with alcoholism with conduct disorder. Alcohol Clin Exp Res 25:177–184.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1111/j.1530-0277.2001.tb02196.x&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=11236830&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000167131100004&link_type=ISI) 

64. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–48.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=13655060&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1959WD28900006&link_type=ISI) 

65. Matsushita S, Muramatsu T, Murayama M, Nakane J, Higuchi S (2001) Alcoholism, ALDH2*2 allele and the A1 allele of the dopamine D2 receptor gene: an association study. Psychiatry Res may be associated with antisocial personality disorder not comorbid with alcoholism. Addict Biol 17:865–874.
    
    

66. Meador-Woodruff JH,Mansour A, Bunzow JR, Van Tol HH,Watson SJ, Civelli O (1989) Distribution of D2 dopamine receptor mRNA in rat brain. Proc Natl Acad Sci USA 86(19):7625–7628.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoicG5hcyI7czo1OiJyZXNpZCI7czoxMDoiODYvMTkvNzYyNSI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIwLzA0LzE4LzIwMjAuMDQuMTUuMjAwNjY0OTguYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 

67. Mignini F, Napolioni V, Codazzo C, Carpi FM, Vitali M, Romeo M, Ceccanti M. (2012) DRD2/ANKK1 TaqIA and SLC6A3 VNTR polymorphisms in alcohol dependence: association and gene-gene interaction study in a population of Central Italy. Neurosci Lett. 522(2):103–7
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=22698582&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 

68. Munafò M, Johnstone E, Murphy M, Walton R: New directions in the genetic mechanisms underlying nicotine addiction. Addict Biol 2001,6:109–17.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1080/13556210020040181&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=11341850&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000168645800001&link_type=ISI) 

69. Munafo MR, Matheson IJ, Flint J. Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case-control studies and evidence of publication bias. Mol Psychiatry. 2007; 12:454–61.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=17453061&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000245947900007&link_type=ISI) 

70. Namkoong K, Cheon KA, Kim JW, Jun JY, Lee JY (2008) Association study of dopamine D2, D4 receptor gene, GABAA Hum Genet (2013) 132:347–358 357.
    
    

71. Neiswanger K, Hill SY, Kaplan BB (1995) Association and linkage studies of the TAQI A1 allele at the dopamine D2 receptor gene in samples of female and male alcoholics. Am J Med Genet 60:267–271.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/ajmg.1320600402&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=7485259&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1995RN77300001&link_type=ISI) 

72. Neville MJ, Johnstone EC, Walton RT (2004) Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 23:540–545.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/humu.20039&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=15146457&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000221727400003&link_type=ISI) 

73. Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ (1991) Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 48:648–654.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1001/archpsyc.1991.01810310066012&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=2069496&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1991FW28300009&link_type=ISI) 

74. Noble EP, Syndulko K, Fitch RJ, Ritchie T, Bohlman MC, Guth P, Sheridan PJ, Montgomery A, Heinzmann C, Sparkes RS et al. (1994) D2 dopamine receptor TaqI A alleles in medically ill alcoholic and nonalcoholic patients. Alcohol Alcohol 29:729–744.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=7695792&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1994QB48400017&link_type=ISI) 

75. Ovchinnikov IV, Druzina E, Ovtchinnikova O, Zagarovskaya T, Nebarakova T, Anokhina AP. Polymorphism of dopamine D2 and D4 receptor genes and Slavic-surnamed alcoholic patients. Addict Biol 1999; 4: 399–404.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=20575808&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 

76. Panduro A, Ramos-Lopez O, Campollo O, Zepeda-Carrillo EA, Gonzalez-Aldaco K, Torres-Valadez R, Roman S (2017) High frequency of the DRD2/ANKK1 A1 allele in Mexican Native Amerindians and Mestizos and its association with alcohol consumption. Drug Alcohol Depend. 2017 Mar 1;172:66–72.
    
    

77. Parsian A, Todd RD, Devor EJ, O’Malley KL, Suarez BK, Reich T,Cloninger CR (1991) Alcoholism and alleles of the human D2 dopamine receptor locus. Studies of association and linkage.Arch Gen Psychiatry 48:655–663.
    
    

78. Pastorelli R, Bardazzi G, Saieva C, Cerri A, Gestri D, Allamani A,Airoldi L, Palli D (2001) Genetic determinants of alcohol addiction and metabolism: a survey in Italy. Alcohol Clin Exp patients. Addict Biol 4:399–404.
    
    

79. Pivonello R, Ferone D, Lombardi G, Colao A, Lamberts SW, Hofland LJ (2007) Novel insights in dopamine receptor physiology. Eur J Endocrinol 156(Suppl 1):S13–S21.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiZWplIjtzOjU6InJlc2lkIjtzOjE1OiIxNTYvc3VwcGxfMS9TMTMiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyMC8wNC8xOC8yMDIwLjA0LjE1LjIwMDY2NDk4LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 

80. Pohjalainen T, Rinne JO, Nagren K, Lehikoinen P, Anttila K,Syvalahti EK, Hietala J (1998) The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 3:256–260.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1038/sj.mp.4000350&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=9672901&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000074005200017&link_type=ISI) 

81. Ponce G, Hoenicka J, Jimenez-Arriero MA, Rodriguez-Jimenez R, Aragues M, Martin-Sune N, Huertas E, Palomo T. DRD2 and ANKK1 genotype in alcohol-dependent patients with psychopathic traits: association and interaction study. Br J Psychiatry. 2008; 193:121–5.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MTA6ImJqcHJjcHN5Y2giO3M6NToicmVzaWQiO3M6OToiMTkzLzIvMTIxIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjAvMDQvMTgvMjAyMC4wNC4xNS4yMDA2NjQ5OC5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

82. Prasad P, Ambekar A, Vaswani M (2010) Dopamine D2 receptor polymorphisms and susceptibility to alcohol dependence in Indian males: a preliminary study. BMC Med Genet 11:24.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=20146828&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 

83. Rai V. 2011. Polymorphism in folate metabolic pathway gene as maternal risk factor for Down syndrome. Int J Biol Med Res., 2(4): 1055–1060.
    
    

84. Rai V. Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) gene and susceptibility to depression in Asian population: a systematic meta-analysis. Cell Mol Biol. 2014; 60 (3): 29–36.
    
    

85. Rai V. Folate pathway gene methylenetetrahydrofolate reductase C677T polymorphism and Alzheimer disease risk in Asian population. Indian J Clin Biochem. 2016; 31(3): 245–52.
    
    

86. Rai V. 2016. Methylenetetrahydrofolate Reductase Gene C677T Polymorphism and Its Association with Ovary Cancer. J Health Med Informat 7:3
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.4172/2157-7420.1000226&link_type=DOI) 

87. Rai V. Strong association of C677T polymorphism of methylenetetrahydrofolate reductase gene with nosyndromic cleft lip/palate (nsCL/P). Ind J Clin Biochem. 2017; 1–11.
    
    

88. Rai V, Yadav U, Kumar P, Yadav SK, Gupta S.2017. Methylenetetrahydrofolate Reductase A1298C Genetic Variant and Risk of Schizophrenia: an updated meta-analysis. Indian J Med Res, 2017;145(4):437–447.
    
    

89. Rai V, Yadva U, Kumar P. Null association of maternal MTHFR A1298C polymorphism with Down syndrome pregnancy: An updated meta-analysis. The Egyptian J Med Hum Genet. 2017; 18(1): 9–18.
    
    

90. Rai V. 2017. Association of C677T polymorphism (rs1801133) in MTHFR gene with depression. Cell Mol Biol, 2017;63(6):60–67.
    
    

91. Rai V, Yadav U, Kumar P. Impact of Catechol-O-Methyltransferase Val 158Met (rs4680) Polymorphism on breast cancer Susceptibility in Asian population. Asian Pac J Cancer Prev. 2017; 18 (5): 1243–1250.
    
    

92. Rai V, Kumar P. Methylenetetrahydrofolate Reductase C677T Polymorphism and Risk for Male Infertility in Asian Population. Ind J Clin. Biochem. 2017; 32(3), 253–260.
    
    

93. Rai V, Kumar P. 2018. Fetal MTHFR C677T polymorphism confers no susceptibility to Down Syndrome: evidence from meta-analysis. Egyptian J Med Hum Genet.19: 53–58.
    
    

94. Rai V, Kumar P. 2018. Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to epilepsy. Neurological Sciences [https://doi.org/10.1007/s10072-018-3583-z](https://doi.org/10.1007/s10072-018-3583-z).
    
    

95. Ragia G, Veresies I, Veresie L, Veresies K, Manolopoulos VG (2016) Association study of DRD2 A2/A1, DRD3 Ser9Gly, DβH -1021C>T, OPRM1 A118G and GRIK1 rs2832407C>A polymorphisms with alcohol dependence. Drug Metab Pers Ther. 31(3):143–50.
    
    

96. Sakai JT, Hopfer CJ, Hartman C, Haberstick BC, Smolen A, Corley RP, Stallings MC, Young SE, Timberlake D, Hewitt JK, Crowley TJ (2007) Test of association between TaqIA A1 allele and alcohol use disorder phenotypes in a sample of adolescent patients with serious substance and behavioral problems. Drug Alcohol Depend 88:130–137.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.drugalcdep.2006.10.002&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=17069991&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000246069000003&link_type=ISI) 

97. Samochowiec J, Ladehoff M, Pelz J, Smolka M, Schmidt LG, Rommelspacher H et al. Predominant influence of the 3’-region of dopamine D2 receptor gene (DRD2) on the clinical phenotype in German alcoholics. Pharmacogenetics 2000; 10: 471–475.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/00008571-200007000-00010&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=10898116&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000087954900010&link_type=ISI) 

98. Samochowiec J, Kucharska-Mazur J, Grzywacz A, Pelka-Wysiecka J, Mak M, Samochowiec A, Bienkowski P. Genetics of Lesch’s typology of alcoholism. Prog Neuropsychopharmacol Biol Psychiatry. 2008; 32:423–7.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.pnpbp.2007.09.013&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=17928119&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 

99. Sander T, Harms H, Podschus J, Finckh U, Nickel B, Rolfs A, Rommelspacher H, Schmidt LG (1995) Dopamine D1, D2 and D3 receptor genes in alcohol dependence. Psychiatr Genet 5:171–176.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=8750359&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1995TN63000004&link_type=ISI) 

100.Sander T, Ladehoff M, Samochowiec J, Finckh U, Rommelspacher H, Schmidt LG. Lack of an allelic association between polymorphisms of the dopamine D2 receptor gene and alcohol dependence in the German population. Alcohol Clin Exp Res 1999; 23: 578–581.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1111/j.1530-0277.1999.tb04157.x&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=10235291&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000079931300003&link_type=ISI) 

101.Schellekens AF, Franke B, Ellenbroek B, Cools A, de Jong CA, Buitelaar JK, Verkes RJ (2012) Reduced Dopamine receptor sensitivity as an intermediate phenotype in alcohol dependence Seagroatt V, Stratton I. Bias in meta-analysis detected by a simple, graphical test. Test had 10% false positive rate. Br Med J 1998; 316: 470; author reply 470–471.
    
    

102.Schwab S, Soyka M, Niederecker M, Sackenheil M, Scherer J, Wilderauer DB. Allelic association of human dopamine D2-receptor DNA polymorphism ruled out in 45 alcoholics. Am J Hum Genet. 1991;49(Suppl):203
    
    

103.Shaikh KJ, Naveen D, Sherrin T, Murthy A, Thennarasu K, Anand A, Benegal V, Jain S (2001) Polymorphisms at the DRD2 locus in early-onset alcohol dependence in the Indian population. Addict Biol 6:331–335.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1080/13556210020077055&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=11900611&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000171113700005&link_type=ISI) 

104.Sibley DR, Monsma FJ Jr. (1992) Molecular biology of dopamine receptors. Trends Pharmacol Sci 13:61–69.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/0165-6147(92)90025-2&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=1561715&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 

105.Singh SH, Ghosh PK, Saraswathy KN. (2013) DRD2 and ANKK1 gene polymorphisms and alcohol dependence: a case-control study among a Mendelian population of East Asian ancestry. Alcohol Alcohol. 48(4):409–14.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/alcalc/agt014&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=23443985&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 

106.Smith L, Watson M, Gates S, Ball D, Foxcroft D. (2008) Meta-analysis of the association of the Taq1A polymorphism with the risk of alcohol dependency: a HuGE gene-disease association review. Am J Epidemiol. 167:125–38.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/aje/kwm281&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=17989061&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000252498200001&link_type=ISI) 

107.Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283(15): 2008–2012.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1001/jama.283.15.2008&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=10789670&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000086436600037&link_type=ISI) 

108.Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, Perry EK et al. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 1997; 7: 479–484.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/00008571-199712000-00006&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=9429233&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1997YK80200006&link_type=ISI) 

109.Tupala E, Tiihonen J: Dopamine and alcoholism: neurobiological basis of ethanol abuse. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:1221–47.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.pnpbp.2004.06.022&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=15588749&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 

110.Vasconcelos ACCG,  de Souza Neto, Pinto GR, Yoshioka FKN, Motta EJN, Vasconcelos DBP, Canalle R(2015) Association Study of the SLC6A3 VNTR (DAT) and DRD2/ANKK1 Taq1A Polymorphisms with Alcohol Dependence in a Population from Northeastern Brazil. Cell and Molecular Biology. [https://doi.org/10.1111/acer.12625](https://doi.org/10.1111/acer.12625)
    
    

111.Wallace BC, Dahabreh IJ, Trikalinos TA, Lau J, Trow P, Schmid CH. Closing the gap between methodologists and end-users: R as a computational back-end. J Stat Softw. 2013; 49: 1–15.
    
    

112.Wang TJ, Huang SY, Lin WW, Lo HY, Wu PL, Wang YS, Wu YS, Ko HC, Shih JC, Lu RB (2007) Possible interaction between MAOA and DRD2 genes associated with antisocial alcoholism among Han Chinese men in Taiwan. Prog Neuropsychopharmacol Biol Psychiatry 31:108–114.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=17007976&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 

113.Wang F, Simen A, Arias A, Lu QW, Zhang H (2013) A large-scale meta-analysis of the association between the ANKK1/DRD2 Taq1A polymorphism and alcohol dependence. Hum Genet. 132(3): 347–358.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s00439-012-1251-6&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=23203481&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 

114.Weiner DM, Brann MR (1989) The distribution of a dopamine D2 receptor mRNA in rat brain. FEBS Lett 253(1–2):207–213.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/0014-5793(89)80960-3&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=2759239&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 

115.Wu CY, Wu YS, Lee JF, Huang SY, Yu L, Ko HC, Lu RB (2008) The association between DRD2/ANKK1, 5-HTTLPR gene, and specific personality trait on antisocial alcoholism among Han Chinese in Taiwan. Am J Med Genet B Neuropsychiatr Genet 147B:447–453.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/ajmg.b.30626&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=17948892&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 

116.Yadav U, Kumar P, Gupta S, Rai V. Role of MTHFR C677T gene polymorphism in the susceptibility of schizophrenia: An updated meta-analysis. Asian J Psychiatry. 2016; 20: 41–51.
    
    

117.Yadav U, Kumar P, Rai V. Role of MTHFR A1298C gene polymorphism in the etiology of prostate cancer:a systematic review and updated meta-analysis. Egyptian Journal Medical Human Genetics. 2016; 17(2): 141–148.
    
    

118.Yadav U, Kumar P, Gupta S, Rai V. Distribution of MTHFR C677T Gene Polymorphism in Healthy North Indian Population and an Updated Meta-analysis. Ind J Clin Biochem. 2017; 32(4), 399-410. ISSN: 0974-0422.
    
    

119.Yadav U, Kumar P, Rai V. NQO1 gene C609T polymorphism (dbSNP: rs1800566) and digestive tract cancer risk: A Meta analysis. Nutrition and Cancer. 2018; doi:10.1080/01635581.20.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1080/01635581.20&link_type=DOI) 

120.Yadav U, Kumar P, Rai V. Distribution of Methionine Synthase Reductase (MTRR) Gene A66G Polymorphism in Indian Population. 2019. Ind J Clin Biochem. ISSN: 0974-0422. [https://doi.org/10.1007/s12291-019-00862-9](https://doi.org/10.1007/s12291-019-00862-9)
    
    

121.Zintzaras E, Ioannidis JP. Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol. 2004;24:1–15.
    
    

122.Zintzaras E, Koufakis T, Ziakas PD, Rodopoulou P, Giannouli S,Voulgarelis M. A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in acute lymphoblastic leukemia. Eur J Epidemiol. 2006;21:501–10.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s10654-006-9027-8&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=16897583&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F04%2F18%2F2020.04.15.20066498.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000241379100003&link_type=ISI)